Preliminary study of pulsed-electromagnetic fields effects on endothelial (HUVEC) cell secretions--modulation of the thrombo-hemorrhagic balance.
← Research streamLow-amplitude magnetic pulse exposure with low repetition frequency modulated secretion of both PGI2 (anti-aggregant) and TXA2 (pro-aggregant) in HUVEC. The modulation depended on pulse frequency, pulse width, and magnetic field intensity, and the authors rep…
Study snapshot
Abstract
We investigated the role of low-amplitude magnetic pulse with low repetition frequency superimposed on the environmental electromagnetic field (EMF) on the secretion of anti-aggregant (Prostacyclin or PGI(2)) and pro-aggregant (Thromboxane A(2)) agents in endothelial cells of the human umbilical cord vein (HUVEC). We established that magnetic pulse exposure modulates both PGI(2) and TXA(2). These modulations depend on the frequency, width of the pulse, and intensity of the magnetic field. Moreover, we corroborated previous results obtained with an endothelial cell line (EaHy-926), concerning the increased thrombo-embolic risk for the 1 Hz frequency.
AI evidence extraction
Structured fields below were generated from the paper’s abstract and metadata to make the evidence easier to inspect. Automated extraction may be incomplete or incorrect; verify important details against the original paper.
Main findings
Low-amplitude magnetic pulse exposure with low repetition frequency modulated secretion of both PGI2 (anti-aggregant) and TXA2 (pro-aggregant) in HUVEC. The modulation depended on pulse frequency, pulse width, and magnetic field intensity, and the authors report increased thrombo-embolic risk at 1 Hz consistent with prior endothelial cell line findings.
Outcomes measured
- Secretion/modulation of prostacyclin (PGI2)
- Secretion/modulation of thromboxane A2 (TXA2)
- Thrombo-hemorrhagic balance / thrombo-embolic risk (inferred from PGI2/TXA2 changes)
Limitations
- In vitro cell model; findings may not translate to humans
- Exposure parameters not fully specified in abstract (e.g., exact field strengths, pulse widths, exposure duration)
- Sample size and statistical details not reported in abstract
View raw extracted JSON
{
"study_type": "in_vitro",
"exposure": {
"band": null,
"source": "pulsed magnetic field superimposed on environmental EMF",
"frequency_mhz": null,
"sar_wkg": null,
"duration": null
},
"population": "Human umbilical cord vein endothelial cells (HUVEC)",
"sample_size": null,
"outcomes": [
"Secretion/modulation of prostacyclin (PGI2)",
"Secretion/modulation of thromboxane A2 (TXA2)",
"Thrombo-hemorrhagic balance / thrombo-embolic risk (inferred from PGI2/TXA2 changes)"
],
"main_findings": "Low-amplitude magnetic pulse exposure with low repetition frequency modulated secretion of both PGI2 (anti-aggregant) and TXA2 (pro-aggregant) in HUVEC. The modulation depended on pulse frequency, pulse width, and magnetic field intensity, and the authors report increased thrombo-embolic risk at 1 Hz consistent with prior endothelial cell line findings.",
"effect_direction": "mixed",
"limitations": [
"In vitro cell model; findings may not translate to humans",
"Exposure parameters not fully specified in abstract (e.g., exact field strengths, pulse widths, exposure duration)",
"Sample size and statistical details not reported in abstract"
],
"evidence_strength": "very_low",
"confidence": 0.74,
"peer_reviewed_likely": "yes",
"keywords": [
"pulsed electromagnetic fields",
"magnetic pulse",
"environmental EMF",
"HUVEC",
"endothelial cells",
"prostacyclin",
"PGI2",
"thromboxane A2",
"TXA2",
"platelet aggregation",
"thrombo-hemorrhagic balance",
"thrombo-embolic risk",
"1 Hz"
],
"suggested_hubs": [
{
"slug": "elf-emf",
"weight": 0.6,
"reason": "Low repetition frequency (e.g., 1 Hz) pulsed magnetic field exposure."
},
{
"slug": "mechanisms-in-vitro",
"weight": 0.85,
"reason": "In vitro endothelial cell secretion changes (PGI2/TXA2) under pulsed magnetic field exposure."
}
]
}AI-extracted fields are generated from the abstract and metadata and may be incomplete or incorrect. This material is for informational purposes and is not medical advice.
Identifiers and source
DOI: 10.1080/15368370802414145
PubMed: 19037787
Related papers
- Extremely low frequency electromagnetic fields (ELF-EMFs) induce in vitro angiogenesis process in human endothelial cells. 2008
- Magnetically Stimulated Myogenesis Recruits a CRY2-TRPC1 Photosensitive Signaling Axis 2025
- Effects of pulsed electromagnetic fields on tumor cell viability: a meta-analysis of in vitro randomized controlled experiments 2021
- The Role of Pulsed Electromagnetic Fields on the Radical Pair Mechanism 2021
- Randomised, placebo-controlled trial of transcranial pulsed EMF in patients with multiple chemical sensitivity 2016
- An Investigation on the Effect of ELF Pulsed Electromagnetic Fields on Human Electrocardiograms 2016